Idhifa

Enasidenib Mesylate

7.9 High risk

Idhifa & Death

27.4%

of users reported Death

95.7%

also reported Death

59.5%

are men

Most common medical consequences

Death

95.7%

Severe reaction

4.1%

Hospitalization

0.2%

Have you experienced any negative side effects from this medication?

Idhifa: general information

Most common side effects (52)

Most commonly affected ages

40 - 49 years

0.9%

50 - 59 years

11.1%

60 - 69 years

27.7%

70 - 79 years

39.7%

80 - 89 years

19.7%

90 - 99 years

0.9%